VALORANT player profile · Europe region · Account level 351 · Title “No Scope” · 0 profile views
Current rank: IMMORTAL 1 - 44 RR (as of last recorded competitive match, 2026-05-29).
Peak recorded rank: IMMORTAL 2 - 111 RR (reached 2026-05-24).
Ranks derive from recorded ranked matches; games played while untracked may not be reflected.
| Tracked matches | 59 |
|---|---|
| Win rate | 60.0% (6 W / 4 L over 13 matches with recorded stats) |
| K/D | 1.00 (243 kills / 243 deaths / 39 assists) |
| Average combat score | 3168 |
| Headshot rate | 35.2% |
| Date | Mode | Map | Agent | Result | K/D/A | ACS | RR |
|---|---|---|---|---|---|---|---|
| 2026-05-30 | Deathmatch | Pearl | - | - | - | - | +0 |
| 2026-05-29 | Competitive | Pearl | - | - | - | - | -16 |
| 2026-05-29 | Competitive | Lotus | - | - | - | - | +19 |
| 2026-05-29 | Competitive | Ascent | Clove | L | 16/14/1 | 301 | -20 |
| 2026-05-29 | Competitive | Breeze | - | - | - | - | -18 |
| 2026-05-29 | Team Deathmatch | Glitch | - | - | - | - | +0 |
| 2026-05-29 | Team Deathmatch | District | - | - | - | - | +0 |
| 2026-05-29 | Deathmatch | Fracture | - | - | - | - | +0 |
| 2026-05-24 | Competitive | Fracture | - | - | - | - | -16 |
| 2026-05-24 | Competitive | Fracture | - | - | - | - | -16 |
| 2026-05-24 | Competitive | Split | - | - | - | - | +21 |
| 2026-05-24 | Competitive | Pearl | Clove | W | 11/23/9 | 142 | +21 |
| 2026-05-24 | Competitive | Haven | - | - | - | - | -16 |
| 2026-05-24 | Competitive | Haven | Phoenix | L | 16/18/3 | 181 | -15 |
| 2026-05-20 | Competitive | Ascent | Phoenix | W | 15/13/3 | 205 | - |
| 2026-05-20 | Competitive | Pearl | Chamber | W | 11/17/0 | 125 | - |
| 2026-05-19 | Competitive | Fracture | Phoenix | L | 8/14/0 | 135 | - |
| 2026-05-19 | Competitive | Pearl | Reyna | L | 12/24/5 | 130 | - |
| 2026-05-19 | Competitive | Pearl | Reyna | W | 19/15/2 | 216 | - |
| 2026-05-19 | Deathmatch | Breeze | - | - | - | - | +0 |
Showing 20 of 59 tracked matches. The interactive profile lists all of them.
No penalty records for this player.